CoChat

Effects of glucose‐lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta‐analysis of randomized control trials

Seidu, S., Achana, F. A., Gray, L. J., Davies, M. J., Khunti, K. · 2016 · Diabetic Medicine
Cited by 43

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Introduction: The effect of intensive glycaemic control alone or as part of a multifactorial intervention on cardiovascular and mortality outcomes is not fully understood. In addition, the interaction of duration of diabetes diagnosis on cardiovascular and mortality outcomes is unclear. Aim: To quantify the effect of intensive treatment (i.e. intensive glucose lowering either alone or as part of a multifactorial intervention) on non‐fatal myocardial infarction (MI), non‐fatal stroke, cardiovascular disease (CV) mortality and all‐cause mortality in patients with Type 2 diabetes. A secondary objective was to investigate the association between the treatment effect and trial‐level characteristics such as average age, duration of Type 2 diabetes, the percentage male and the baseline event rate. Methods: We searched MEDLINE, Embase and the Cochrane Central Register of Controlled Trials without language restrictions from inception to 13 May 2015. We included randomized controlled trials (RCT s) that evaluated intensive treatment in adult patients with Type 2 diabetes. The review was registered on PROSPERO (registration number 42014013860). We pooled rates across studies using random effects meta‐analysis and investigated study‐level covariate associations using Bayesian meta‐regression. Results: A total of 19 RCT s were included: 16 examined non‐fatal MI (n = 79 595), 14 non‐fatal stroke (n = 78 568), 18 cardiovascular mortality (n = 83 938) and 18 all‐cause mortality (n = 84 266). There was evidence to suggest that compared with standard care, intensive treatment reduced the risk of non‐fatal MI [risk ratio (RR) 0.90, 95% confidence interval (CI) 0.83–0.96], but not non‐fatal stroke (RR 0.96, 95% CI 0.86–1.07), CV mortality (RR 1.00, 95% CI 0.90–1.11) or all‐cause mortality (RR 1.00, 95% CI 0.94–1.06). Compared with standard care, multifactorial interventions alone reduced non‐fatal stroke (RR 0.53, 95% CI 0.32–0.0.87) but not non‐fatal MI (RR 0.66, 95% CI 0.38–1.03), CV mortality (RR 0.72, 95% CI 0.46–1.14) or all‐cause mortality (RR 0.82, 95% CI 0.64–1.05). There was no evidence to suggest that the effect of intensive treatment on cardiovascular and mortality outcomes was associated with mean age, mean duration of Type 2 diabetes and percentage of male patients across trials. There was evidence to suggest that the effectiveness of intensive treatment to reduce mortality outcomes increases as the baseline incidence of cardiovascular mortality [ratio of hazard = 0.82, 95% credible interval (CrI) 0.65–0.99] increased across trials, but not baseline incidence of non‐fatal MI, non‐fatal stroke and all‐cause mortality. Intensive glucose‐lowering and multifactorial interventions are predicted to have the desired beneficial effect of reducing CVD mortality in populations where the incidence rate is greater than about 6.3 CVD deaths per 1000 person‐years or an average 10–year CVD risk of 6.3%. Conclusions: Apart from non‐fatal MI s, there was no evidence that intensive glucose‐lowering and multifactorial interventions reduced or increased the risk of cardiovascular and mortality outcomes. Intensive glucose‐lowering and multifactorial interventions are likely to be beneficial in populations with a higher baseline incidence of CV mortality, but there was no evidence of an association with the mean duration of Type 2 diabetes. Multifactorial interventions had a much greater impact on non‐fatal MI and non‐fatal strokes. (PROSPERO registration no.: 42014013860)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dme.12885

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 43

Metadata

Authors
Seidu, S., Achana, F. A., Gray, L. J., Davies, M. J., & Khunti, K.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2015-09-08
Volume
33
Issue
3
Pages
280-289
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2145191561
Cited by
43
References
9
FWCI
3.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of glucose‐lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta‐analysis of randomized control trials. https://app.cochat.ai/papers/10.1111/dme.12885
The paper
Seidu, S., Achana, F. A., Gray, L. J., Davies, M. J., & Khunti, K. (2016). Effects of glucose‐lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta‐analysis of randomized control trials. Diabetic Medicine. https://doi.org/10.1111/dme.12885

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.